82 related articles for article (PubMed ID: 7206301)
1. [Effect of pantethine on the lipoprotein abnormalities in survivors of cerebral infarction (author's transl)].
Murai A; Miyahara T; Tanaka T; Sako Y; Kameyama M; Nishimura N
Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):624-9. PubMed ID: 7206301
[No Abstract] [Full Text] [Related]
2. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
Artery; 1985; 12(4):234-43. PubMed ID: 3935096
[TBL] [Abstract][Full Text] [Related]
3. [The relationships of HDL- and LDL-cholesterol to cerebral infarction and to atherosclerosis--clinical and pathological study (author's transl)].
Yamanouchi H; Tohgi H; Okabe H; Shimada H
Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):148-52. PubMed ID: 7289181
[No Abstract] [Full Text] [Related]
4. Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits.
Tomikawa M; Nakayasu T; Tawara K; Kameda KY; Abiko Y
Atherosclerosis; 1982 Feb; 41(2-3):267-77. PubMed ID: 7066075
[TBL] [Abstract][Full Text] [Related]
5. [Hyperlipidemia, diabetes and atherosclerosis: efficacy of treatment with pantethine].
Arsenio L; Caronna S; Lateana M; Magnati G; Strata A; Zammarchi G
Acta Biomed Ateneo Parmense; 1984; 55(1):25-42. PubMed ID: 6232801
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
[TBL] [Abstract][Full Text] [Related]
7. [Vitamin E megadoses and their effect on HDL cholesterol levels in patients with atherosclerotic complications (author's transl)].
Turay J; Beseda I; Michalcová A
Cas Lek Cesk; 1981 Dec; 120(48):1432-4. PubMed ID: 6947861
[No Abstract] [Full Text] [Related]
8. [Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment].
Bergesio F; Ciuti R; Innocenti D; Galli GA; Frizzi V
G Clin Med; 1985; 66(11-12):433-40. PubMed ID: 3835087
[No Abstract] [Full Text] [Related]
9. [HDL cholesterol, LDL cholesterol and cerebral infarction].
Murai A; Miyahara T
Nihon Rinsho; 1982; 40(10):2172-6. PubMed ID: 7166827
[No Abstract] [Full Text] [Related]
10. [Serum lipids levels, lipoprotein phenotypes and analysis of lipoprotein in Italian population group (author's transl)].
Avogaro P; Cazzolato G; Capri C; Pais M; Trabuio GF
G Ital Cardiol; 1974; 4(2):237-48. PubMed ID: 4365662
[No Abstract] [Full Text] [Related]
11. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
Bruck J; Fischer M; Tschabitscher H
Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
[TBL] [Abstract][Full Text] [Related]
12. Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
Farina R; Lovati MR; Raucci G; Sirtori CR
Pharmacol Res Commun; 1982 Jun; 14(6):499-510. PubMed ID: 7122675
[No Abstract] [Full Text] [Related]
13. [Statistical research on the lipides electrophoresis and on double pre-beta lipoprotein (author's transl)].
La Paglia S; Liverani F
Quad Sclavo Diagn; 1976 Jun; 12(2):173-9. PubMed ID: 193141
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of ingestion of vitamin E on lipoprotein-cholesterol fractions in healthy adults.
Bolster M; Duggan PF; Cole M; Crowley M
Ir Med J; 1983 Mar; 76(3):152-4. PubMed ID: 6574998
[No Abstract] [Full Text] [Related]
15. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia].
Arsenio L; Bodria P; Bossi S; Lateana M; Strata A
Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754
[TBL] [Abstract][Full Text] [Related]
16. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia.
Gaddi A; Descovich GC; Noseda G; Fragiacomo C; Colombo L; Craveri A; Montanari G; Sirtori CR
Atherosclerosis; 1984 Jan; 50(1):73-83. PubMed ID: 6365107
[TBL] [Abstract][Full Text] [Related]
17. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits.
Carrara P; Matturri L; Galbussera M; Lovati MR; Franceschini G; Sirtori CR
Atherosclerosis; 1984 Dec; 53(3):255-64. PubMed ID: 6442152
[TBL] [Abstract][Full Text] [Related]
18. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
Jaillard J; Sezille G; Dewailly P; Fruchart JC
Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
[TBL] [Abstract][Full Text] [Related]
19. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
Lu ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
[No Abstract] [Full Text] [Related]
20. [High density lipoproteins: the status quo (author's transl)].
Kostner GM
Wien Klin Wochenschr; 1980 Oct; 92(19):665-72. PubMed ID: 7467341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
